Table 2.
Ref. | Study Design | BD vs. Controls | Model | Major Cell Type(s) |
---|---|---|---|---|
[63] | BD I (LR)—control | 3 vs. 3 | iPSC | Forebrain, mixed glutamatergic—GABAergic neurons |
[64] | BD I—control | 12 vs. 6 | iNLC | NSC, NPC, neuronal-like cells |
[65] | Familial BD | 2 vs. 2 | iPSC | FACS-sorted NPCs, neurons |
[66] | BD I—control | 6 vs. 4 | iPSC | Hippocampal dentate gyrus-like granule neurons |
[67] | BD I—control | 1 vs. 1 5 vs. 3 |
iPSC iNLC |
NPC, NPC-derived neurons transdifferentiated neurons |
[68] | Familial BD | 4 vs. 4 | iPSC | PAX6-positive NPC, early and late cortical neurons |
[69] | BD I (LR-NR)—control | 3 vs. 3 vs. 4 | iPSC | Hippocampal dentate gyrus-like granule neurons |
[70] | BD I (LR-NR)—control—MDD—PD | 7 vs. 3 vs. 6 vs. 2 vs. 1 | iPSC | Forebrain, mixed glutamatergic—GABAergic neurons |
[71] | BD I—control | 6 vs. 4 | iPSC | Cortical stem and progenitor cells |
BD I, bipolar disease type I; FACS, fluorescence activated cell sorting; iNLC, induced neuron-like cells; iPSC, induced pluripotent stem cell; MDD, unipolar major depression; LR, lithium responder; NPC, neural progenitor cell; NSC, neural stem cell; NR, lithium non-responder; PD, Parkinson disease.